The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...

In this article, we are going to take a look at where Pfizer Inc. (NYSE:PFE) stands against the other beaten down dividend ...

In this article, we are going to take a look at where Pfizer Inc. (NYSE:PFE) stands against the other buzzing stocks.

Below is Validea's guru fundamental report for PFIZER INC (PFE). Of the 22 guru strategies we follow, PFE rates highest using our Value Investor model based on the published strategy of Benjamin ...

Below is Validea's guru fundamental report for PFIZER INC (PFE). Of the 22 guru strategies we follow, PFE rates highest using our Value Investor model based on the published strategy of Benjamin ...

J.P. Morgan analyst Chris Schott maintained a Hold rating on Pfizer (PFE – Research Report) today and set a price target of $30.00. The company’s shares closed last Friday at $28.58.

Rating agencies say the average payout ratio since 2010 is 50.4% vs. 60% or less safe. PFE's big growth spike is courtesy of a recovery from an epic once-in-a-lifetime event, the 200% sales spike ...

The latest trading session saw Pfizer (PFE) ending at $28.97, denoting a +0.14% adjustment from its last day's close. This move lagged the S&P 500's daily gain of 0.4%. At the same time ...

In a report released today, Terence Flynn from Morgan Stanley maintained a Hold rating on Pfizer (PFE – Research Report), with a price target of $30.00. The company’s shares closed yesterday ...

Investors interested in stocks from the Large Cap Pharmaceuticals sector have probably already heard of Pfizer (PFE) and Novo Nordisk (NVO). But which of these two stocks presents investors with ...